-
1.
公开(公告)号:EP4321220A3
公开(公告)日:2024-03-20
申请号:EP23209713.9
申请日:2018-11-30
申请人: CSL Behring LLC
发明人: Uknis, Marc , Voigt, Christine , Baheti, Gautam , Roberts, John
摘要: This disclosure relates to methods for preventing or reducing the risk of development of graft versus host disease (GVHD) in patients receiving hematopoietic cell transplantation (HCT) by particular methods of administering alpha-1 antitrypsin (A 1A or AAT) to patients both prior to and following and HCT procedure. The disclosure also relates to specific methods of treating acute GVHD (aGVHD) after HCT with A1AT.
-
公开(公告)号:EP4172335A1
公开(公告)日:2023-05-03
申请号:EP21745541.9
申请日:2021-06-25
申请人: CSL Behring LLC
IPC分类号: C12N15/113 , C12N9/22 , C12N5/0783 , A61P7/00
-
公开(公告)号:EP3898978A2
公开(公告)日:2021-10-27
申请号:EP19842997.9
申请日:2019-12-23
申请人: CSL Behring LLC
发明人: YAN, Ming , BARTLETT, Jeffrey S.
IPC分类号: C12N15/113 , C12N9/22 , A61K9/51 , A61K48/00 , A61K31/7088
-
4.
公开(公告)号:EP3716998A1
公开(公告)日:2020-10-07
申请号:EP18821851.5
申请日:2018-11-30
申请人: CSL Behring LLC
发明人: UKNIS, Marc , VOIGT, Christine , BAHETI, Gautam , ROBERTS, John
-
公开(公告)号:EP3006462B1
公开(公告)日:2019-04-10
申请号:EP15193455.1
申请日:2003-12-19
申请人: CSL Behring LLC
发明人: Kee, Scott M. , Cook, Paul I. , Smith, James R. , Kling, Robert , Fowler, Scott A , Weber, David
IPC分类号: C07K14/81
-
公开(公告)号:EP2295126B1
公开(公告)日:2015-12-16
申请号:EP10182334.2
申请日:2003-12-19
申请人: CSL Behring LLC
发明人: Cook, Paul I. , Fowler, Scott A , Kee, Scott M. , Smith, James R. , Weber, David , Kling, Robert
IPC分类号: C07K14/81
CPC分类号: A61K38/57 , A61K9/19 , B01D15/327 , B01D15/363 , C07K14/8125 , G01N30/461
摘要: A streamlined method for purifying alpha-1-antitrypsin (AAT) from an AAT-containing protein mixture, such as a Cohn fraction IV precipitate, is provided. In the method of the invention, contaminating proteins are destabilized by cleavage of disulfide bonds with a reducing reagent, such as a dithiol, which does not affect AAT. The destabilized proteins are then preferentially adsorbed on a solid protein-adsorbing material, without the addition of a salt as a precipitant. Separation of the solid adsorbent from the solution leaves a purified AAT solution that is directly suitable for chromatographic purification, without the need for extensive desalting as in prior art processes. A process incorporating this method, which provides pharmaceutical grade AAT in high yield on a commercial scale, is also described.
摘要翻译: 提供了从含有AAT的蛋白质混合物如Cohn馏分IV沉淀物中纯化α-1-抗胰蛋白酶(AAT)的流线型方法。 在本发明的方法中,通过用不影响AAT的还原剂如二硫醇裂解二硫键,污染蛋白质不稳定。 然后将不稳定的蛋白质优先吸附在固体蛋白质吸附材料上,而不加入作为沉淀剂的盐。 固体吸附剂与溶液的分离留下直接适用于色谱纯化的纯化的AAT溶液,而不需像现有技术方法那样进行广泛的脱盐。 还描述了一种以商业规模提供高产量的药物级AAT的方法。
-
公开(公告)号:EP2904005A1
公开(公告)日:2015-08-12
申请号:EP13777203.4
申请日:2013-10-01
申请人: CSL Behring LLC
发明人: BRINKMAN, Nathan
CPC分类号: C07K14/805 , C07K14/4717
摘要: The present invention relates generally to a method of purifying proteins. More specifically, the present inventions relates to a method of purifying haptoglobin and hemopexin from the same starting material, and uses thereof.
摘要翻译: 本发明一般涉及纯化蛋白质的方法。 更具体地说,本发明涉及从相同的起始材料中纯化触珠蛋白和血红素结合蛋白的方法及其用途。
-
公开(公告)号:EP2295126A1
公开(公告)日:2011-03-16
申请号:EP10182334.2
申请日:2003-12-19
申请人: CSL Behring LLC
发明人: Cook, Paul I. , Fowler, Scott A , Kee, Scott M. , Smith, James R. , Weber, David , Kling, Robert
CPC分类号: A61K38/57 , A61K9/19 , B01D15/327 , B01D15/363 , C07K14/8125 , G01N30/461
摘要: A streamlined method for purifying alpha-1-antitrypsin (AAT) from an AAT-containing protein mixture, such as a Cohn fraction IV precipitate, is provided. In the method of the invention, contaminating proteins are destabilized by cleavage of disulfide bonds with a reducing reagent, such as a dithiol, which does not affect AAT. The destabilized proteins are then preferentially adsorbed on a solid protein-adsorbing material, without the addition of a salt as a precipitant. Separation of the solid adsorbent from the solution leaves a purified AAT solution that is directly suitable for chromatographic purification, without the need for extensive desalting as in prior art processes. A process incorporating this method, which provides pharmaceutical grade AAT in high yield on a commercial scale, is also described.
-
公开(公告)号:EP3897745A1
公开(公告)日:2021-10-27
申请号:EP19842992.0
申请日:2019-12-23
申请人: CSL Behring LLC
IPC分类号: A61K48/00 , A61K35/28 , C12N15/867
-
10.
公开(公告)号:EP4321220A2
公开(公告)日:2024-02-14
申请号:EP23209713.9
申请日:2018-11-30
申请人: CSL Behring LLC
发明人: Uknis, Marc , Voigt, Christine , Baheti, Gautam , Roberts, John
IPC分类号: A61P37/06
摘要: This disclosure relates to methods for preventing or reducing the risk of development of graft versus host disease (GVHD) in patients receiving hematopoietic cell transplantation (HCT) by particular methods of administering alpha-1 antitrypsin (A 1A or AAT) to patients both prior to and following and HCT procedure. The disclosure also relates to specific methods of treating acute GVHD (aGVHD) after HCT with A1AT.
-
-
-
-
-
-
-
-
-